CRISPR/ Cas9: A Toolbox with Clinical Potential-Juniper Publishers
The CRISPR/ Cas9 machinery, which is known to provide adaptive immunity
to bacteria and archeae, has been proven an efficient tool for genome
editing in a wide range of organisms. It is an RNA-guided DNA
endonuclease that introduces double-stranded breaks in the target DNA.
This compact machinery has been adapted and is being widely used for
precise editing and modification of the genome [1]. This review focuses
on genome editing using the CRISPR/ Cas9 system for correction of
genetic diseases. Here, we review examples from literature where the
CRISPR/ Cas9 system has been used for the correction of Duchenne
Muscular Dystrophy (DMD), cataract caused due to mutations in the Crygc
gene, cystic fibrosis, and sickle cell disease.
For more Open access journals please click on https://juniperpublishers.com/
For more articles please click on https://juniperpublishers.com/ijcsmb/index.php
For more articles please click on https://juniperpublishers.com/ijcsmb/index.php
Comments
Post a Comment